Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 856 of 1,261
  1. US 8512712

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  2. US 8513197

    Ganglioside epitopes for treating Guillain-Barre syndrome

    Georgia Regents University · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  3. US 8512693

    Self-assembling membranes and related methods thereof

    Northwestern University · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  4. US 8512964

    Targets for treatment of hypercholesterolemia

    The Regents of the University of California · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  5. US 8513198

    Pharmaceutical formulation for reducing pain

    Jazz Pharmaceuticals International III Limited · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  6. US 8512258

    Breath test device and method

    EXALENZ BIOSCIENCE LTD. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  7. US 8513244

    Neprilysin inhibitors

    Theravance, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  8. US 8513230

    Nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  9. US 8513282

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  10. US 8513209

    Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair

    The Board of Regents of the University of Texas System · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  11. US 8512751

    Pharmaceutical compositions for sleep disorders

    Collegium Pharmaceutical, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  12. US 8513432

    Dual-acting benzoimidazole antihypertensive agents

    Theravance, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  13. US 8513252

    Pyrazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  14. US 8513279

    Quinuclidine derivatives and medicinal compositions containing the same

    Almirall, S.A. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  15. US 8513414

    Processes and intermediates for producing azaindoles

    Vertex Pharmaceuticals Incorporated · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  16. US 8513489

    Uses of antimicrobial genes from microbial genome

    The Regents of the University of California · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  17. US 8513390

    Modified antibody compositions, methods of making and using thereof

    CytomX Therapeutics, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  18. US 8513302

    Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids

    The Regents of the University of California · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  19. US 8513251

    Pyridazinone compounds

    Takeda Pharmaceutical Company Limited · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  20. US 2013210912

    Ophthalmic Pharmaceutical Compositions and Methods of Making and Using Same

    BAUSCH & LOMB [US] · Granted Aug 15, 2013 · Expires Aug 10, 2033

    granted
  21. AU 2012210489

    IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

    4SC DISCOVERY GMBH [DE] · Granted Aug 15, 2013 · Expires Aug 10, 2033

    granted
  22. AU 2012210491

    IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

    4SC DISCOVERY GMBH [DE] · Granted Aug 15, 2013 · Expires Aug 10, 2033

    granted
  23. CA 2864029

    NOUVELLES UTILISATIONS PEDIATRIQUES DU CABAZITAXEL

    AVENTIS PHARMA SA [FR] · Granted Aug 15, 2013 · Expires Aug 10, 2033

    granted
  24. US 2013209398

    CONDITIONED CELL CULTURE MEDIUM COMPOSITIONS AND METHODS OF USE

    ALLERGAN INC [US] · Granted Aug 15, 2013 · Expires Aug 10, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.